Literature DB >> 16490477

Evaluation of severe infection and survival after splenectomy.

Moe H Kyaw1, Eileen M Holmes, Francis Toolis, Beverley Wayne, Jim Chalmers, Ian G Jones, Harry Campbell.   

Abstract

PURPOSE: Splenectomized patients are known to be at risk of severe infection, but the extent of risk is unclear. We evaluated the incidence of severe infection and survival in 1648 splenectomized patients.
METHODS: Patients who underwent splenectomy between 1988 and 1999 in Scotland were identified through the Scottish hospital discharge records (SMR01) and then linked to the death certificate data recorded by the General Register Office in Scotland to obtain clinical and demographical information.
RESULTS: The overall rate of first severe infection was 7.0 per 100 person-years (95% confidence interval, 6.30-7.78). The overall rate for a second infection per 100 person-years was 44.9 and 109.3 for a third infection after the first episode of infection. Among the repeated episodes of severe infection, 42% to 76% and 61% to 84% of total episodes of second and third severe infection, respectively, occurred within 6 months after the first severe infection. The susceptibility to severe infection was greatest in older age groups (5.5 per 100 person-years in those aged > 50 years) and in patients splenectomized for hematologic malignancy (9.2), and iatrogenic splenectomy for malignancy disease (7.4). Between 50% and 80% of all severe infections or deaths occurred within 1 to 3 years after splenectomy.
CONCLUSIONS: The risk of severe infection is an important health problem in splenectomized patients, especially in those who underwent surgery for malignancies. Antibiotic prophylaxis could offer the most benefits in the first 3 years postsplenectomy or the first 6 months after the occurrence of a first severe infection.

Entities:  

Mesh:

Year:  2006        PMID: 16490477     DOI: 10.1016/j.amjmed.2005.07.044

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

Review 1.  Splenic regeneration following splenectomy and impact on sepsis: a clinical review.

Authors:  Manuel Riera; Simon Buczacki; Zulfiqar A J Khan
Journal:  J R Soc Med       Date:  2009-04       Impact factor: 5.344

2.  A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

Authors:  Ye-Jun Wu; Ming Hou; Hui-Xin Liu; Jun Peng; Liang-Ming Ma; Lin-Hua Yang; Ru Feng; Hui Liu; Yi Liu; Jia Feng; Hong-Yu Zhang; Ze-Ping Zhou; Wen-Sheng Wang; Xu-Liang Shen; Peng Zhao; Hai-Xia Fu; Qiao-Zhu Zeng; Xing-Lin Wang; Qiu-Sha Huang; Yun He; Qian Jiang; Hao Jiang; Jin Lu; Xiang-Yu Zhao; Xiao-Su Zhao; Ying-Jun Chang; Lan-Ping Xu; Yue-Ying Li; Qian-Fei Wang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2020-11-24

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Preventing infections in children and adults with asplenia.

Authors:  Grace M Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

5.  Middle segment pancreatectomy can be safely incorporated into a pancreatic surgeon's clinical practice.

Authors:  Harish Lavu; Jamie L Knuth; Marshall S Baker; Changyu Shen; Nicholas J Zyromski; Max Schmidt; Atilla Nakeeb; Thomas J Howard
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 6.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

7.  Clearance of pathological antibodies using biomimetic nanoparticles.

Authors:  Jonathan A Copp; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

8.  The role of TLR2 in the host response to pneumococcal pneumonia in absence of the spleen.

Authors:  Adriana J J Lammers; Alexander P N A de Porto; Onno J de Boer; Sandrine Florquin; Tom van der Poll
Journal:  BMC Infect Dis       Date:  2012-06-21       Impact factor: 3.090

9.  Splenectomy for hematological disorders in Iranian pediatric patients: a single center study.

Authors:  Bibi Shahin Shamsian; Mohammad Thaghi Arzanian; Raheleh Kaviani; Samin Alavi; Mona Hedayat; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

10.  Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study.

Authors:  J Chong; P Jones; D Spelman; K Leder; A C Cheng
Journal:  Epidemiol Infect       Date:  2016-10-25       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.